Amarin Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AMARIN PHARMS, and when can generic versions of AMARIN PHARMS drugs launch?
AMARIN PHARMS has two approved drugs.
There are sixty-three US patents protecting AMARIN PHARMS drugs.
There are three hundred and twenty-eight patent family members on AMARIN PHARMS drugs in forty-six countries and twenty-one supplementary protection certificates in thirteen countries.
Drugs and US Patents for Amarin Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 9,693,986 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 11,154,526 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,415,335 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 11,116,742 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 10,278,937 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | AB | RX | Yes | No | 8,410,086 | ⤷ Subscribe | ⤷ Subscribe | |||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | AB | RX | Yes | Yes | 8,440,650 | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Amarin Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | 8,188,146 | ⤷ Subscribe |
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-002 | Feb 16, 2017 | 8,188,146 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for AMARIN PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2013-01-15 |
➤ Subscribe | Capsules | 500 mg | ➤ Subscribe | 2017-08-29 |
➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2016-07-26 |
International Patents for Amarin Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Australia | 2020294210 | ⤷ Subscribe |
Costa Rica | 20140591 | ⤷ Subscribe |
New Zealand | 743714 | ⤷ Subscribe |
Portugal | 2596786 | ⤷ Subscribe |
South Africa | 201105612 | ⤷ Subscribe |
South Korea | 20120016677 | ⤷ Subscribe |
Spain | 2661217 | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Amarin Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2443246 | 122021000056 | Germany | ⤷ Subscribe | PRODUCT NAME: VAZKEPA (ICOSAPENT ETHYL); REGISTRATION NO/DATE: EU/1/20/1524 20210326 |
2022495 | 132021000000154 | Italy | ⤷ Subscribe | PRODUCT NAME: ICOSAPENT ETILE(VAZKEPA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1524, 20210329 |
2443246 | 132021000000156 | Italy | ⤷ Subscribe | PRODUCT NAME: ICOSAPENT ETILE(VAZKEPA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1524, 20210329 |
2443246 | 21C1046 | France | ⤷ Subscribe | PRODUCT NAME: ICOSAPENT ETHYL; NAT. REGISTRATION NO/DATE: EU/1/20/1524 20210329; FIRST REGISTRATION: - EU/1/20/1524 20210329 |
2443246 | 301137 | Netherlands | ⤷ Subscribe | PRODUCT NAME: ICOSAPENT-ETHYL; REGISTRATION NO/DATE: EU/1/20/1524 20210329 |
2443246 | CA 2021 00036 | Denmark | ⤷ Subscribe | PRODUCT NAME: ICOSAPENT ETHYL; REG. NO/DATE: EU/1/20/1524 20210329 |
2443246 | PA2021522,C2443246 | Lithuania | ⤷ Subscribe | PRODUCT NAME: IKOZAPENTO ETILAS; REGISTRATION NO/DATE: EU/1/20/1524 20210326 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.